Astelin nasal spray
Company: Wallace Laboratories
Approval Status: Approved November 1996
Treatment for: seasonal allergic rhinitis
Areas: Pulmonary/Respiratory Diseases
General Information
Other Useful Resources
Astelin nasal spray has been approved for the treatment of symptoms associated with seasonal allergic rhinitis.
It offers a valuable treatment option for the estimated 20-40 million Americans who suffer from seasonal allergic rhinitis, the fifth most common chronic illness that causes millions of lost work days and significant discomfort for the sufferer.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
